跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NOUMED CANDESARTAN/HCT 32/12.5 candesartan cilexetil/hydrochlorothiazide 32 mg/12.5 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
NOUMED CANDESARTAN/HCT 32/12.5 candesartan cilexetil/hydrochlorothiazide 32 mg/12.5 mg tablet blister pack
Approved
STANDARD
NOUMED CANDESARTAN/HCT 32/12.5 candesartan cilexetil/hydrochlorothiazide 32 mg/12.5 mg tablet blister pack
Avallon Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
9856236958776fa1
Company
Avallon Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
9856236958776fa1
Product Name
NOUMED CANDESARTAN/HCT 32/12.5 candesartan cilexetil/hydrochlorothiazide 32 mg/12.5 mg tablet blister pack
Artg Id
285582
Artg Name
NOUMED CANDESARTAN/HCT 32/12.5 candesartan cilexetil/hydrochlorothiazide 32 mg/12.5 mg tablet blister pack
Sponsor
Avallon Pharmaceuticals Pty Ltd
Company Detail Path
/organization/avallon-pharmaceuticals-pty-limited
Artg Date
2017-06-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/e5a5e225273054264b58a52ef5bb836f.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
9856236958776fa1
Type
Standard
Back to TGA Approvals